Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Biological Unit 1
(-)Biological Unit 2
(-)Biological Unit 3
(-)Biological Unit 4
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)
Image Biological Unit 3
Biological Unit 3  (Jmol Viewer)
Image Biological Unit 4
Biological Unit 4  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
 
Authors :  O. A. Ibrahimi, A. V. Eliseenkova, A. N. Plotnikov, D. M. Ornitz, M. Mohammadi
Date :  23 Apr 01  (Deposition) - 09 May 01  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.30
Chains :  Asym. Unit :  A,B,C,D,E,F,G,H
Biol. Unit 1:  A,E  (1x)
Biol. Unit 2:  B,F  (1x)
Biol. Unit 3:  C,G  (1x)
Biol. Unit 4:  D,H  (1x)
Keywords :  Immunoglobulin Like Domain, B-Trefoil, Growth Factor/Growth Factor Receptor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  O. A. Ibrahimi, A. V. Eliseenkova, A. N. Plotnikov, K. Yu, D. M. Ornitz, M. Mohammadi
Structural Basis For Fibroblast Growth Factor Receptor 2 Activation In Apert Syndrome.
Proc. Natl. Acad. Sci. Usa V. 98 7182 2001
PubMed-ID: 11390973  |  Reference-DOI: 10.1073/PNAS.121183798
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - HEPARIN-BINDING GROWTH FACTOR 2
    ChainsA, B, C, D
    EngineeredYES
    Expression SystemESCHERICHIA COLI BL21(DE3)
    Expression System PlasmidPET-28A
    Expression System StrainBL21(DE3)
    Expression System Taxid469008
    Expression System Vector TypePLASMID
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymFGF2, HBGF-2, BASIC FIBROBLAST GROWTH FACTOR, BFGF
 
Molecule 2 - FIBROBLAST GROWTH FACTOR RECEPTOR 2
    ChainsE, F, G, H
    EC Number2.7.1.112
    EngineeredYES
    Expression SystemESCHERICHIA COLI BL21(DE3)
    Expression System PlasmidPET-28A
    Expression System StrainBL21(DE3)
    Expression System Taxid469008
    Expression System Vector TypePLASMID
    FragmentEXTRACELLULAR LIGAND BINDING DOMAIN CONSISTING OF IG-LIKE DOMAINS II (D2) AND III (D3), RESIDUES 147-366
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymFGFR2, KERATINOCYTE GROWTH FACTOR RECEPTOR

 Structural Features

(-) Chains, Units

  12345678
Asymmetric Unit ABCDEFGH
Biological Unit 1 (1x)A   E   
Biological Unit 2 (1x) B   F  
Biological Unit 3 (1x)  C   G 
Biological Unit 4 (1x)   D   H

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (0, 0)

(no "Ligand,Modified Residues,Ions" information available for 1IIL)

(-) Sites  (0, 0)

(no "Site" information available for 1IIL)

(-) SS Bonds  (8, 8)

Asymmetric Unit
No.Residues
1E:179 -E:231
2E:278 -E:342
3F:179 -F:231
4F:278 -F:342
5G:179 -G:231
6G:278 -G:342
7H:179 -H:231
8H:278 -H:342

(-) Cis Peptide Bonds  (8, 8)

Asymmetric Unit
No.Residues
1Asn E:184 -Pro E:185
2Leu E:262 -Pro E:263
3Asn F:184 -Pro F:185
4Leu F:262 -Pro F:263
5Asn G:184 -Pro G:185
6Leu G:262 -Pro G:263
7Asn H:184 -Pro H:185
8Leu H:262 -Pro H:263

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (47, 184)

Asymmetric Unit (47, 184)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_017259A172FFGFR2_HUMANDisease (PS)  ---E/F/G/HA172F
02UniProtVAR_017260M186TFGFR2_HUMANPolymorphism755793E/F/G/HM186T
03UniProtVAR_036380R203CFGFR2_HUMANUnclassified  ---E/F/G/HR203C
04UniProtVAR_004114S252FFGFR2_HUMANDisease (APRS)121918498E/F/G/HS252F
05UniProtVAR_004113S252LFGFR2_HUMANDisease (CS)79184941E/F/G/HS252L
06UniProtVAR_004115S252WFGFR2_HUMANDisease (PS)79184941E/F/G/HS252W
07UniProtVAR_004117P253RFGFR2_HUMANDisease (APRS)77543610E/F/G/HR253R
08UniProtVAR_017261P263LFGFR2_HUMANDisease (CS)779326224E/F/G/HP263L
09UniProtVAR_004118S267PFGFR2_HUMANDisease (CS)121918505E/F/G/HS267P
10UniProtVAR_042205G272VFGFR2_HUMANUnclassified  ---E/F/G/HG272V
11UniProtVAR_004120F276VFGFR2_HUMANDisease (CS)  ---E/F/G/HF276V
12UniProtVAR_004121C278FFGFR2_HUMANDisease (PS)776587763E/F/G/HC278F
13UniProtVAR_017263C278YFGFR2_HUMANDisease (CS)  ---E/F/G/HC278Y
14UniProtVAR_017264Y281CFGFR2_HUMANDisease (CS)  ---E/F/G/HY281C
15UniProtVAR_042206D283NFGFR2_HUMANUnclassified  ---E/F/G/HD283N
16UniProtVAR_017265I288SFGFR2_HUMANDisease (CS)  ---E/F/G/HI288S
17UniProtVAR_004123Q289PFGFR2_HUMANDisease (JWS)121918497E/F/G/HQ289P
18UniProtVAR_004124W290CFGFR2_HUMANDisease (PS)121918499E/F/G/HW290C
19UniProtVAR_017266W290GFGFR2_HUMANDisease (CS)121918501E/F/G/HW290G
20UniProtVAR_004125W290RFGFR2_HUMANDisease (CS)121918501E/F/G/HW290R
21UniProtVAR_004126K292EFGFR2_HUMANDisease (CS)121918500E/F/G/HK292E
22UniProtVAR_004127Y301CFGFR2_HUMANDisease (CS)  ---G/HY301C
23UniProtVAR_004128A314SFGFR2_HUMANUnclassified  ---E/F/G/HA314S
24UniProtVAR_017267A315SFGFR2_HUMANPolymorphism121918504E/F/G/HA315S
25UniProtVAR_004129D321AFGFR2_HUMANDisease (PS)121918510E/F/G/HD321A
26UniProtVAR_004130Y328CFGFR2_HUMANDisease (CS)121918493E/F/G/HY328C
27UniProtVAR_004131N331IFGFR2_HUMANDisease (CS)  ---E/F/G/HN331I
28UniProtVAR_017268A337PFGFR2_HUMANDisease (CS)387906676E/F/G/HA337P
29UniProtVAR_004133G338EFGFR2_HUMANDisease (CS)  ---E/F/G/HG338E
30UniProtVAR_015011G338RFGFR2_HUMANDisease (CS)  ---E/F/G/HG338R
31UniProtVAR_017269Y340CFGFR2_HUMANDisease (PS)  ---E/F/G/HY340C
32UniProtVAR_004134Y340HFGFR2_HUMANDisease (CS)121918489E/F/G/HY340H
33UniProtVAR_004135T341PFGFR2_HUMANDisease (PS)121918495E/F/G/HT341P
34UniProtVAR_004136C342FFGFR2_HUMANDisease (CS)  ---E/F/G/HC342F
35UniProtVAR_017270C342GFGFR2_HUMANDisease (PS)  ---E/F/G/HC342G
36UniProtVAR_004137C342RFGFR2_HUMANDisease (PS)121918488E/F/G/HC342R
37UniProtVAR_004138C342SFGFR2_HUMANDisease (PS)121918488E/F/G/HC342S
38UniProtVAR_017271C342WFGFR2_HUMANDisease (CS)121918496E/F/G/HC342W
39UniProtVAR_004139C342YFGFR2_HUMANDisease (PS)121918487E/F/G/HC342Y
40UniProtVAR_004140A344GFGFR2_HUMANDisease (JWS)121918492E/F/G/HA344G
41UniProtVAR_004141A344PFGFR2_HUMANDisease (PS)  ---E/F/G/HA344P
42UniProtVAR_004142S347CFGFR2_HUMANDisease (CS)121918494E/F/G/HS347C
43UniProtVAR_004143S351CFGFR2_HUMANDisease (PS)121918502E/F/G/HS351C
44UniProtVAR_004144S354CFGFR2_HUMANDisease (CS)121918490E/F/G/HS354C
45UniProtVAR_017272S354YFGFR2_HUMANDisease (CS)  ---E/F/G/HS354Y
46UniProtVAR_004146V359FFGFR2_HUMANDisease (PS)  ---E/F/G/HV359F
47UniProtVAR_017273A362SFGFR2_HUMANDisease (CS)  ---G/HA362S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (45, 45)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_017259A172FFGFR2_HUMANDisease (PS)  ---EA172F
02UniProtVAR_017260M186TFGFR2_HUMANPolymorphism755793EM186T
03UniProtVAR_036380R203CFGFR2_HUMANUnclassified  ---ER203C
04UniProtVAR_004114S252FFGFR2_HUMANDisease (APRS)121918498ES252F
05UniProtVAR_004113S252LFGFR2_HUMANDisease (CS)79184941ES252L
06UniProtVAR_004115S252WFGFR2_HUMANDisease (PS)79184941ES252W
07UniProtVAR_004117P253RFGFR2_HUMANDisease (APRS)77543610ER253R
08UniProtVAR_017261P263LFGFR2_HUMANDisease (CS)779326224EP263L
09UniProtVAR_004118S267PFGFR2_HUMANDisease (CS)121918505ES267P
10UniProtVAR_042205G272VFGFR2_HUMANUnclassified  ---EG272V
11UniProtVAR_004120F276VFGFR2_HUMANDisease (CS)  ---EF276V
12UniProtVAR_004121C278FFGFR2_HUMANDisease (PS)776587763EC278F
13UniProtVAR_017263C278YFGFR2_HUMANDisease (CS)  ---EC278Y
14UniProtVAR_017264Y281CFGFR2_HUMANDisease (CS)  ---EY281C
15UniProtVAR_042206D283NFGFR2_HUMANUnclassified  ---ED283N
16UniProtVAR_017265I288SFGFR2_HUMANDisease (CS)  ---EI288S
17UniProtVAR_004123Q289PFGFR2_HUMANDisease (JWS)121918497EQ289P
18UniProtVAR_004124W290CFGFR2_HUMANDisease (PS)121918499EW290C
19UniProtVAR_017266W290GFGFR2_HUMANDisease (CS)121918501EW290G
20UniProtVAR_004125W290RFGFR2_HUMANDisease (CS)121918501EW290R
21UniProtVAR_004126K292EFGFR2_HUMANDisease (CS)121918500EK292E
23UniProtVAR_004128A314SFGFR2_HUMANUnclassified  ---EA314S
24UniProtVAR_017267A315SFGFR2_HUMANPolymorphism121918504EA315S
25UniProtVAR_004129D321AFGFR2_HUMANDisease (PS)121918510ED321A
26UniProtVAR_004130Y328CFGFR2_HUMANDisease (CS)121918493EY328C
27UniProtVAR_004131N331IFGFR2_HUMANDisease (CS)  ---EN331I
28UniProtVAR_017268A337PFGFR2_HUMANDisease (CS)387906676EA337P
29UniProtVAR_004133G338EFGFR2_HUMANDisease (CS)  ---EG338E
30UniProtVAR_015011G338RFGFR2_HUMANDisease (CS)  ---EG338R
31UniProtVAR_017269Y340CFGFR2_HUMANDisease (PS)  ---EY340C
32UniProtVAR_004134Y340HFGFR2_HUMANDisease (CS)121918489EY340H
33UniProtVAR_004135T341PFGFR2_HUMANDisease (PS)121918495ET341P
34UniProtVAR_004136C342FFGFR2_HUMANDisease (CS)  ---EC342F
35UniProtVAR_017270C342GFGFR2_HUMANDisease (PS)  ---EC342G
36UniProtVAR_004137C342RFGFR2_HUMANDisease (PS)121918488EC342R
37UniProtVAR_004138C342SFGFR2_HUMANDisease (PS)121918488EC342S
38UniProtVAR_017271C342WFGFR2_HUMANDisease (CS)121918496EC342W
39UniProtVAR_004139C342YFGFR2_HUMANDisease (PS)121918487EC342Y
40UniProtVAR_004140A344GFGFR2_HUMANDisease (JWS)121918492EA344G
41UniProtVAR_004141A344PFGFR2_HUMANDisease (PS)  ---EA344P
42UniProtVAR_004142S347CFGFR2_HUMANDisease (CS)121918494ES347C
43UniProtVAR_004143S351CFGFR2_HUMANDisease (PS)121918502ES351C
44UniProtVAR_004144S354CFGFR2_HUMANDisease (CS)121918490ES354C
45UniProtVAR_017272S354YFGFR2_HUMANDisease (CS)  ---ES354Y
46UniProtVAR_004146V359FFGFR2_HUMANDisease (PS)  ---EV359F

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (45, 45)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_017259A172FFGFR2_HUMANDisease (PS)  ---FA172F
02UniProtVAR_017260M186TFGFR2_HUMANPolymorphism755793FM186T
03UniProtVAR_036380R203CFGFR2_HUMANUnclassified  ---FR203C
04UniProtVAR_004114S252FFGFR2_HUMANDisease (APRS)121918498FS252F
05UniProtVAR_004113S252LFGFR2_HUMANDisease (CS)79184941FS252L
06UniProtVAR_004115S252WFGFR2_HUMANDisease (PS)79184941FS252W
07UniProtVAR_004117P253RFGFR2_HUMANDisease (APRS)77543610FR253R
08UniProtVAR_017261P263LFGFR2_HUMANDisease (CS)779326224FP263L
09UniProtVAR_004118S267PFGFR2_HUMANDisease (CS)121918505FS267P
10UniProtVAR_042205G272VFGFR2_HUMANUnclassified  ---FG272V
11UniProtVAR_004120F276VFGFR2_HUMANDisease (CS)  ---FF276V
12UniProtVAR_004121C278FFGFR2_HUMANDisease (PS)776587763FC278F
13UniProtVAR_017263C278YFGFR2_HUMANDisease (CS)  ---FC278Y
14UniProtVAR_017264Y281CFGFR2_HUMANDisease (CS)  ---FY281C
15UniProtVAR_042206D283NFGFR2_HUMANUnclassified  ---FD283N
16UniProtVAR_017265I288SFGFR2_HUMANDisease (CS)  ---FI288S
17UniProtVAR_004123Q289PFGFR2_HUMANDisease (JWS)121918497FQ289P
18UniProtVAR_004124W290CFGFR2_HUMANDisease (PS)121918499FW290C
19UniProtVAR_017266W290GFGFR2_HUMANDisease (CS)121918501FW290G
20UniProtVAR_004125W290RFGFR2_HUMANDisease (CS)121918501FW290R
21UniProtVAR_004126K292EFGFR2_HUMANDisease (CS)121918500FK292E
23UniProtVAR_004128A314SFGFR2_HUMANUnclassified  ---FA314S
24UniProtVAR_017267A315SFGFR2_HUMANPolymorphism121918504FA315S
25UniProtVAR_004129D321AFGFR2_HUMANDisease (PS)121918510FD321A
26UniProtVAR_004130Y328CFGFR2_HUMANDisease (CS)121918493FY328C
27UniProtVAR_004131N331IFGFR2_HUMANDisease (CS)  ---FN331I
28UniProtVAR_017268A337PFGFR2_HUMANDisease (CS)387906676FA337P
29UniProtVAR_004133G338EFGFR2_HUMANDisease (CS)  ---FG338E
30UniProtVAR_015011G338RFGFR2_HUMANDisease (CS)  ---FG338R
31UniProtVAR_017269Y340CFGFR2_HUMANDisease (PS)  ---FY340C
32UniProtVAR_004134Y340HFGFR2_HUMANDisease (CS)121918489FY340H
33UniProtVAR_004135T341PFGFR2_HUMANDisease (PS)121918495FT341P
34UniProtVAR_004136C342FFGFR2_HUMANDisease (CS)  ---FC342F
35UniProtVAR_017270C342GFGFR2_HUMANDisease (PS)  ---FC342G
36UniProtVAR_004137C342RFGFR2_HUMANDisease (PS)121918488FC342R
37UniProtVAR_004138C342SFGFR2_HUMANDisease (PS)121918488FC342S
38UniProtVAR_017271C342WFGFR2_HUMANDisease (CS)121918496FC342W
39UniProtVAR_004139C342YFGFR2_HUMANDisease (PS)121918487FC342Y
40UniProtVAR_004140A344GFGFR2_HUMANDisease (JWS)121918492FA344G
41UniProtVAR_004141A344PFGFR2_HUMANDisease (PS)  ---FA344P
42UniProtVAR_004142S347CFGFR2_HUMANDisease (CS)121918494FS347C
43UniProtVAR_004143S351CFGFR2_HUMANDisease (PS)121918502FS351C
44UniProtVAR_004144S354CFGFR2_HUMANDisease (CS)121918490FS354C
45UniProtVAR_017272S354YFGFR2_HUMANDisease (CS)  ---FS354Y
46UniProtVAR_004146V359FFGFR2_HUMANDisease (PS)  ---FV359F

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 3 (47, 47)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_017259A172FFGFR2_HUMANDisease (PS)  ---GA172F
02UniProtVAR_017260M186TFGFR2_HUMANPolymorphism755793GM186T
03UniProtVAR_036380R203CFGFR2_HUMANUnclassified  ---GR203C
04UniProtVAR_004114S252FFGFR2_HUMANDisease (APRS)121918498GS252F
05UniProtVAR_004113S252LFGFR2_HUMANDisease (CS)79184941GS252L
06UniProtVAR_004115S252WFGFR2_HUMANDisease (PS)79184941GS252W
07UniProtVAR_004117P253RFGFR2_HUMANDisease (APRS)77543610GR253R
08UniProtVAR_017261P263LFGFR2_HUMANDisease (CS)779326224GP263L
09UniProtVAR_004118S267PFGFR2_HUMANDisease (CS)121918505GS267P
10UniProtVAR_042205G272VFGFR2_HUMANUnclassified  ---GG272V
11UniProtVAR_004120F276VFGFR2_HUMANDisease (CS)  ---GF276V
12UniProtVAR_004121C278FFGFR2_HUMANDisease (PS)776587763GC278F
13UniProtVAR_017263C278YFGFR2_HUMANDisease (CS)  ---GC278Y
14UniProtVAR_017264Y281CFGFR2_HUMANDisease (CS)  ---GY281C
15UniProtVAR_042206D283NFGFR2_HUMANUnclassified  ---GD283N
16UniProtVAR_017265I288SFGFR2_HUMANDisease (CS)  ---GI288S
17UniProtVAR_004123Q289PFGFR2_HUMANDisease (JWS)121918497GQ289P
18UniProtVAR_004124W290CFGFR2_HUMANDisease (PS)121918499GW290C
19UniProtVAR_017266W290GFGFR2_HUMANDisease (CS)121918501GW290G
20UniProtVAR_004125W290RFGFR2_HUMANDisease (CS)121918501GW290R
21UniProtVAR_004126K292EFGFR2_HUMANDisease (CS)121918500GK292E
22UniProtVAR_004127Y301CFGFR2_HUMANDisease (CS)  ---GY301C
23UniProtVAR_004128A314SFGFR2_HUMANUnclassified  ---GA314S
24UniProtVAR_017267A315SFGFR2_HUMANPolymorphism121918504GA315S
25UniProtVAR_004129D321AFGFR2_HUMANDisease (PS)121918510GD321A
26UniProtVAR_004130Y328CFGFR2_HUMANDisease (CS)121918493GY328C
27UniProtVAR_004131N331IFGFR2_HUMANDisease (CS)  ---GN331I
28UniProtVAR_017268A337PFGFR2_HUMANDisease (CS)387906676GA337P
29UniProtVAR_004133G338EFGFR2_HUMANDisease (CS)  ---GG338E
30UniProtVAR_015011G338RFGFR2_HUMANDisease (CS)  ---GG338R
31UniProtVAR_017269Y340CFGFR2_HUMANDisease (PS)  ---GY340C
32UniProtVAR_004134Y340HFGFR2_HUMANDisease (CS)121918489GY340H
33UniProtVAR_004135T341PFGFR2_HUMANDisease (PS)121918495GT341P
34UniProtVAR_004136C342FFGFR2_HUMANDisease (CS)  ---GC342F
35UniProtVAR_017270C342GFGFR2_HUMANDisease (PS)  ---GC342G
36UniProtVAR_004137C342RFGFR2_HUMANDisease (PS)121918488GC342R
37UniProtVAR_004138C342SFGFR2_HUMANDisease (PS)121918488GC342S
38UniProtVAR_017271C342WFGFR2_HUMANDisease (CS)121918496GC342W
39UniProtVAR_004139C342YFGFR2_HUMANDisease (PS)121918487GC342Y
40UniProtVAR_004140A344GFGFR2_HUMANDisease (JWS)121918492GA344G
41UniProtVAR_004141A344PFGFR2_HUMANDisease (PS)  ---GA344P
42UniProtVAR_004142S347CFGFR2_HUMANDisease (CS)121918494GS347C
43UniProtVAR_004143S351CFGFR2_HUMANDisease (PS)121918502GS351C
44UniProtVAR_004144S354CFGFR2_HUMANDisease (CS)121918490GS354C
45UniProtVAR_017272S354YFGFR2_HUMANDisease (CS)  ---GS354Y
46UniProtVAR_004146V359FFGFR2_HUMANDisease (PS)  ---GV359F
47UniProtVAR_017273A362SFGFR2_HUMANDisease (CS)  ---GA362S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 4 (47, 47)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_017259A172FFGFR2_HUMANDisease (PS)  ---HA172F
02UniProtVAR_017260M186TFGFR2_HUMANPolymorphism755793HM186T
03UniProtVAR_036380R203CFGFR2_HUMANUnclassified  ---HR203C
04UniProtVAR_004114S252FFGFR2_HUMANDisease (APRS)121918498HS252F
05UniProtVAR_004113S252LFGFR2_HUMANDisease (CS)79184941HS252L
06UniProtVAR_004115S252WFGFR2_HUMANDisease (PS)79184941HS252W
07UniProtVAR_004117P253RFGFR2_HUMANDisease (APRS)77543610HR253R
08UniProtVAR_017261P263LFGFR2_HUMANDisease (CS)779326224HP263L
09UniProtVAR_004118S267PFGFR2_HUMANDisease (CS)121918505HS267P
10UniProtVAR_042205G272VFGFR2_HUMANUnclassified  ---HG272V
11UniProtVAR_004120F276VFGFR2_HUMANDisease (CS)  ---HF276V
12UniProtVAR_004121C278FFGFR2_HUMANDisease (PS)776587763HC278F
13UniProtVAR_017263C278YFGFR2_HUMANDisease (CS)  ---HC278Y
14UniProtVAR_017264Y281CFGFR2_HUMANDisease (CS)  ---HY281C
15UniProtVAR_042206D283NFGFR2_HUMANUnclassified  ---HD283N
16UniProtVAR_017265I288SFGFR2_HUMANDisease (CS)  ---HI288S
17UniProtVAR_004123Q289PFGFR2_HUMANDisease (JWS)121918497HQ289P
18UniProtVAR_004124W290CFGFR2_HUMANDisease (PS)121918499HW290C
19UniProtVAR_017266W290GFGFR2_HUMANDisease (CS)121918501HW290G
20UniProtVAR_004125W290RFGFR2_HUMANDisease (CS)121918501HW290R
21UniProtVAR_004126K292EFGFR2_HUMANDisease (CS)121918500HK292E
22UniProtVAR_004127Y301CFGFR2_HUMANDisease (CS)  ---HY301C
23UniProtVAR_004128A314SFGFR2_HUMANUnclassified  ---HA314S
24UniProtVAR_017267A315SFGFR2_HUMANPolymorphism121918504HA315S
25UniProtVAR_004129D321AFGFR2_HUMANDisease (PS)121918510HD321A
26UniProtVAR_004130Y328CFGFR2_HUMANDisease (CS)121918493HY328C
27UniProtVAR_004131N331IFGFR2_HUMANDisease (CS)  ---HN331I
28UniProtVAR_017268A337PFGFR2_HUMANDisease (CS)387906676HA337P
29UniProtVAR_004133G338EFGFR2_HUMANDisease (CS)  ---HG338E
30UniProtVAR_015011G338RFGFR2_HUMANDisease (CS)  ---HG338R
31UniProtVAR_017269Y340CFGFR2_HUMANDisease (PS)  ---HY340C
32UniProtVAR_004134Y340HFGFR2_HUMANDisease (CS)121918489HY340H
33UniProtVAR_004135T341PFGFR2_HUMANDisease (PS)121918495HT341P
34UniProtVAR_004136C342FFGFR2_HUMANDisease (CS)  ---HC342F
35UniProtVAR_017270C342GFGFR2_HUMANDisease (PS)  ---HC342G
36UniProtVAR_004137C342RFGFR2_HUMANDisease (PS)121918488HC342R
37UniProtVAR_004138C342SFGFR2_HUMANDisease (PS)121918488HC342S
38UniProtVAR_017271C342WFGFR2_HUMANDisease (CS)121918496HC342W
39UniProtVAR_004139C342YFGFR2_HUMANDisease (PS)121918487HC342Y
40UniProtVAR_004140A344GFGFR2_HUMANDisease (JWS)121918492HA344G
41UniProtVAR_004141A344PFGFR2_HUMANDisease (PS)  ---HA344P
42UniProtVAR_004142S347CFGFR2_HUMANDisease (CS)121918494HS347C
43UniProtVAR_004143S351CFGFR2_HUMANDisease (PS)121918502HS351C
44UniProtVAR_004144S354CFGFR2_HUMANDisease (CS)121918490HS354C
45UniProtVAR_017272S354YFGFR2_HUMANDisease (CS)  ---HS354Y
46UniProtVAR_004146V359FFGFR2_HUMANDisease (PS)  ---HV359F
47UniProtVAR_017273A362SFGFR2_HUMANDisease (CS)  ---HA362S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 4)

Asymmetric Unit (1, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF2_HUMAN222-245
 
 
 
  4A:89-112
B:89-112
C:89-112
D:89-112
Biological Unit 1 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF2_HUMAN222-245
 
 
 
  1A:89-112
-
-
-
Biological Unit 2 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF2_HUMAN222-245
 
 
 
  1-
B:89-112
-
-
Biological Unit 3 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF2_HUMAN222-245
 
 
 
  1-
-
C:89-112
-
Biological Unit 4 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF2_HUMAN222-245
 
 
 
  1-
-
-
D:89-112

(-) Exons   (9, 34)

Asymmetric Unit (9, 34)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000002644981ENSE00001081612chr4:123747863-123748507645FGF2_HUMAN1-1931934A:22-60
B:22-60
C:24-60
D:23-60
39
39
37
38
1.2ENST000002644982ENSE00000970285chr4:123797476-123797579104FGF2_HUMAN193-227354A:60-94
B:60-94
C:60-94
D:60-94
35
35
35
35
1.3bENST000002644983bENSE00001081614chr4:123813366-1238193916026FGF2_HUMAN228-288614A:95-155
B:95-154
C:95-155
D:95-154
61
60
61
60

2.1hENST000003584871hENSE00001816393chr10:123357598-123357476123FGFR2_HUMAN-00--
2.3aENST000003584873aENSE00002141262chr10:123353481-123353223259FGFR2_HUMAN1-37370--
2.5bENST000003584875bENSE00001099029chr10:123325218-123324952267FGFR2_HUMAN37-126900--
2.6aENST000003584876aENSE00001099020chr10:123324093-12332401678FGFR2_HUMAN126-152274E:150-152
F:150-152
G:150-152
H:150-152
3
3
3
3
2.7ENST000003584877ENSE00001295614chr10:123310973-123310804170FGFR2_HUMAN152-208574E:152-208
F:152-208
G:152-208
H:152-208
57
57
57
57
2.8ENST000003584878ENSE00000812216chr10:123298229-123298106124FGFR2_HUMAN209-250424E:209-250
F:209-250
G:209-250
H:209-250
42
42
42
42
2.15ENST0000035848715ENSE00001099035chr10:123279683-123279493191FGFR2_HUMAN250-313644E:250-313 (gaps)
F:250-313 (gaps)
G:250-313
H:250-313
64
64
64
64
2.18bENST0000035848718bENSE00001146218chr10:123276977-123276833145FGFR2_HUMAN314-362494E:314-361
F:314-361
G:314-362
H:314-362
48
48
49
49
2.19cENST0000035848719cENSE00001448727chr10:123274833-123274631203FGFR2_HUMAN362-429682-
-
G:362-364
H:362-364
-
-
3
3
2.21ENST0000035848721ENSE00001015834chr10:123263455-123263304152FGFR2_HUMAN430-480510--
2.22ENST0000035848722ENSE00001627890chr10:123260461-123260340122FGFR2_HUMAN480-521420--
2.23ENST0000035848723ENSE00001146272chr10:123258119-123258009111FGFR2_HUMAN521-558380--
2.24ENST0000035848724ENSE00001146264chr10:123256236-123256046191FGFR2_HUMAN558-621640--
2.25ENST0000035848725ENSE00001099037chr10:123247627-123247505123FGFR2_HUMAN622-662410--
2.26ENST0000035848726ENSE00001099030chr10:123246938-12324686871FGFR2_HUMAN663-686240--
2.27ENST0000035848727ENSE00001146235chr10:123245046-123244909138FGFR2_HUMAN686-732470--
2.28bENST0000035848728bENSE00002167762chr10:123243317-123243212106FGFR2_HUMAN732-767360--
2.31hENST0000035848731hENSE00001847306chr10:123239535-1232378551681FGFR2_HUMAN768-821540--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:134
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:134
                                   164       174       184       194       204       214       224       234       244       254       264       274       284    
           FGF2_HUMAN   155 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 288
               SCOP domains d1iila_ A: Basic FGF (FGF2)                                                                                                            SCOP domains
               CATH domains 1iilA00 A:22-155  [code=2.80.10.50, no name defined]                                                                                   CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ........eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee........eeeee.....eeeee.................hhhhh...hhhh.eeeee... Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------HBGF_FGF  PDB: A:89-112 ------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1  PDB: A:22-60 UniProt: 1-193  ----------------------------------Exon 1.3b  PDB: A:95-155 UniProt: 228-288                     Transcript 1 (1)
           Transcript 1 (2) --------------------------------------Exon 1.2  PDB: A:60-94             ------------------------------------------------------------- Transcript 1 (2)
                 1iil A  22 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 155
                                    31        41        51        61        71        81        91       101       111       121       131       141       151    

Chain B from PDB  Type:PROTEIN  Length:133
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:133
                                   164       174       184       194       204       214       224       234       244       254       264       274       284   
           FGF2_HUMAN   155 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 287
               SCOP domains d1iilb_ B: Basic FGF (FGF2)                                                                                                           SCOP domains
               CATH domains 1iilB00 B:22-154  [code=2.80.10.50, no name defined]                                                                                  CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ........eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee........eeeee.....eeeee.................hhhhh...hhhh.eeeee.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------HBGF_FGF  PDB: B:89-112 ------------------------------------------ PROSITE
           Transcript 1 (1) Exon 1.1  PDB: B:22-60 UniProt: 1-193  ----------------------------------Exon 1.3b  PDB: B:95-154 UniProt: 228-288 [INCOMPLETE]       Transcript 1 (1)
           Transcript 1 (2) --------------------------------------Exon 1.2  PDB: B:60-94             ------------------------------------------------------------ Transcript 1 (2)
                 1iil B  22 PPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 154
                                    31        41        51        61        71        81        91       101       111       121       131       141       151   

Chain C from PDB  Type:PROTEIN  Length:132
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:132
                                   166       176       186       196       206       216       226       236       246       256       266       276       286  
           FGF2_HUMAN   157 GHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 288
               SCOP domains d1iilc_ C: Basic FGF (FGF2)                                                                                                          SCOP domains
               CATH domains 1iilC00 C:24-155  [code=2.80.10.50, no name defined]                                                                                 CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ......eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee...hhhh.eeeee.....eeeee.................hhhhh...hhhh.eeeee... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE -----------------------------------------------------------------HBGF_FGF  PDB: C:89-112 ------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1  PDB: C:24-60 UniProt: 1-193----------------------------------Exon 1.3b  PDB: C:95-155 UniProt: 228-288                     Transcript 1 (1)
           Transcript 1 (2) ------------------------------------Exon 1.2  PDB: C:60-94             ------------------------------------------------------------- Transcript 1 (2)
                 1iil C  24 GHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 155
                                    33        43        53        63        73        83        93       103       113       123       133       143       153  

Chain D from PDB  Type:PROTEIN  Length:132
 aligned with FGF2_HUMAN | P09038 from UniProtKB/Swiss-Prot  Length:288

    Alignment length:132
                                   165       175       185       195       205       215       225       235       245       255       265       275       285  
           FGF2_HUMAN   156 PGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 287
               SCOP domains d1iild_ D: Basic FGF (FGF2)                                                                                                          SCOP domains
               CATH domains 1iilD00 D:23-154  [code=2.80.10.50, no name defined]                                                                                 CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .......eeeee....eeeee.....eeee....hhhh.eeeeeee..eeeeee....eeeee.....eeee...hhhh.eeeee.....eeeee.................hhhhh...hhhh.eeeee.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------HBGF_FGF  PDB: D:89-112 ------------------------------------------ PROSITE
           Transcript 1 (1) Exon 1.1  PDB: D:23-60 UniProt: 1-193 ----------------------------------Exon 1.3b  PDB: D:95-154 UniProt: 228-288 [INCOMPLETE]       Transcript 1 (1)
           Transcript 1 (2) -------------------------------------Exon 1.2  PDB: D:60-94             ------------------------------------------------------------ Transcript 1 (2)
                 1iil D  23 PGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVSANRYLAMKEDGRLLASKSVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAK 154
                                    32        42        52        62        72        82        92       102       112       122       132       142       152  

Chain E from PDB  Type:PROTEIN  Length:200
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:212
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359  
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
               SCOP domains d1iile1 E:150-250 Fibroblast growth factor receptor, FGFR                                            d1iile2 E:251-361 Fibroblast growth factor r            eceptor, FGFR                                           SCOP domains
               CATH domains 1iilE01 E:150-250 Immunoglobulins                                                                    1iilE02 E:251-357 Immunoglobulins                                                                          ---- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee.------------..eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E---------------------SS-----A------C--I-----PE-CPF-G--C---C--C----F-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y------------------- SAPs(SNPs) (6)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: E:250-313 (gaps) UniProt: 250-313               Exon 2.18b  PDB: E:314-361 UniProt: 314-362      Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: E:152-208 UniProt: 152-208                Exon 2.8  PDB: E:209-250 UniProt: 209-250 --------------------------------------------------------------------------------------------------------------- Transcript 2 (2)
                 1iil E 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHV------------PYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289    |    -       309       319       329       339       349       359  
                                                                                                                                                                          294          307                                                      

Chain F from PDB  Type:PROTEIN  Length:200
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:212
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359  
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
               SCOP domains d1iilf1 F:150-250 Fibroblast growth factor receptor, FGFR                                            d1iilf2 F:251-361 Fibroblast growth factor r            eceptor, FGFR                                           SCOP domains
               CATH domains 1iilF01 F:150-250 Immunoglobulins                                                                    1iilF02 F:251-357 Immunoglobulins                                                                          ---- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee.------------..eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E---------------------SS-----A------C--I-----PE-CPF-G--C---C--C----F-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y------------------- SAPs(SNPs) (6)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: F:250-313 (gaps) UniProt: 250-313               Exon 2.18b  PDB: F:314-361 UniProt: 314-362      Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: F:152-208 UniProt: 152-208                Exon 2.8  PDB: F:209-250 UniProt: 209-250 --------------------------------------------------------------------------------------------------------------- Transcript 2 (2)
                 1iil F 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHV------------PYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLP 361
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289    |    -       309       319       329       339       349       359  
                                                                                                                                                                          294          307                                                      

Chain G from PDB  Type:PROTEIN  Length:215
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:215
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359     
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
               SCOP domains d1iilg1 G:150-250 Fibroblast growth factor receptor, FGFR                                            d1iilg2 G:251-364 Fibroblast growth factor receptor, FGFR                                                          SCOP domains
               CATH domains 1iilG01 G:150-250 Immunoglobulins                                                                    1iilG02 G:251-357 Immunoglobulins                                                                          ------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee...............eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee.... Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E--------C------------SS-----A------C--I-----PE-CPF-G--C---C--C----F--S-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y---------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R---------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S---------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W---------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y---------------------- SAPs(SNPs) (6)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: G:250-313 UniProt: 250-313                      Exon 2.18b  PDB: G:314-362 UniProt: 314-362      -- Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: G:152-208 UniProt: 152-208                Exon 2.8  PDB: G:209-250 UniProt: 209-250 ---------------------------------------------------------------------------------------------------------------2.1 Transcript 2 (2)
                 1iil G 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359     

Chain H from PDB  Type:PROTEIN  Length:215
 aligned with FGFR2_HUMAN | P21802 from UniProtKB/Swiss-Prot  Length:821

    Alignment length:215
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359     
          FGFR2_HUMAN   150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
               SCOP domains d1iilh1 H:150-250 Fibroblast growth factor receptor, FGFR                                            d1iilh2 H:251-364 Fibroblast growth factor receptor, FGFR                                                          SCOP domains
               CATH domains 1iilH01 H:150-250 Immunoglobulins                                                                    1iilH02 H:251-357 Immunoglobulins                                                                          ------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee.hhhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eeee....eeee..ee.....eeeeeee...............eeeeee.....hhhhh.eeee...hhhhheeeeeeee....eeeeeeeeeee.... Sec.struct. author
             SAPs(SNPs) (1) ----------------------F-------------T----------------C------------------------------------------------FR---------L---P----V---V-F--C-N----SPC-E--------C------------SS-----A------C--I-----PE-CPF-G--C---C--C----F--S-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------------------L-------------------------Y-----------G-----------------------------------------------R-H-G-P---------Y---------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------------------------------------------------------------------W-------------------------------------R---------------------------------------------------R---------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------S---------------------- SAPs(SNPs) (4)
             SAPs(SNPs) (5) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------W---------------------- SAPs(SNPs) (5)
             SAPs(SNPs) (6) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Y---------------------- SAPs(SNPs) (6)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 2 (1) 2.6-------------------------------------------------------------------------------------------------Exon 2.15  PDB: H:250-313 UniProt: 250-313                      Exon 2.18b  PDB: H:314-362 UniProt: 314-362      -- Transcript 2 (1)
           Transcript 2 (2) --Exon 2.7  PDB: H:152-208 UniProt: 152-208                Exon 2.8  PDB: H:209-250 UniProt: 209-250 ---------------------------------------------------------------------------------------------------------------2.1 Transcript 2 (2)
                 1iil H 150 NKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSRHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPG 364
                                   159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359     

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 12)

Asymmetric Unit

(-) CATH Domains  (2, 12)

Asymmetric Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 1IIL)

(-) Gene Ontology  (176, 199)

Asymmetric Unit(hide GO term definitions)
Chain A,B,C,D   (FGF2_HUMAN | P09038)
molecular function
    GO:0016303    1-phosphatidylinositol-3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
    GO:0005088    Ras guanyl-nucleotide exchange factor activity    Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
    GO:0042056    chemoattractant activity    Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
    GO:0005125    cytokine activity    Functions to control the survival, growth, differentiation and effector function of tissues and cells.
    GO:0005104    fibroblast growth factor receptor binding    Interacting selectively and non-covalently with the fibroblast growth factor receptor (FGFR).
    GO:0008083    growth factor activity    The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
    GO:0008201    heparin binding    Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
    GO:0030374    ligand-dependent nuclear receptor transcription coactivator activity    The function of a transcription cofactor that activates transcription in conjuction with a ligand-dependent nuclear receptor from a RNA polymerase II promoter; does not bind DNA itself.
    GO:0046934    phosphatidylinositol-4,5-bisphosphate 3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
biological process
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0007265    Ras protein signal transduction    A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.
    GO:0000187    activation of MAPK activity    The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0009887    animal organ morphogenesis    Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
    GO:0001658    branching involved in ureteric bud morphogenesis    The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0002042    cell migration involved in sprouting angiogenesis    The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
    GO:0006935    chemotaxis    The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
    GO:0060591    chondroblast differentiation    The process in which a mesenchymal cell, acquires specialized structural and/or functional features of a chondroblast. Differentiation includes the processes involved in commitment of a cell to a chondroblast fate. A chondroblast is a precursor cell to chondrocytes.
    GO:0048598    embryonic morphogenesis    The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0008543    fibroblast growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
    GO:0014843    growth factor dependent regulation of skeletal muscle satellite cell proliferation    Any process that modulates the frequency, rate or extent of satellite cell proliferation; dependent on specific growth factor activity such as fibroblast growth factors and transforming growth factor beta.
    GO:0030214    hyaluronan catabolic process    The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
    GO:0032958    inositol phosphate biosynthetic process    The chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0043537    negative regulation of blood vessel endothelial cell migration    Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
    GO:0060548    negative regulation of cell death    Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
    GO:0010764    negative regulation of fibroblast migration    Any process that decreases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
    GO:0061045    negative regulation of wound healing    Any process that decreases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
    GO:0007399    nervous system development    The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0006661    phosphatidylinositol biosynthetic process    The chemical reactions and pathways resulting in the formation of phosphatidylinositol, any glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
    GO:0046854    phosphatidylinositol phosphorylation    The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
    GO:0036092    phosphatidylinositol-3-phosphate biosynthetic process    The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
    GO:0048015    phosphatidylinositol-mediated signaling    A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
    GO:0050918    positive chemotaxis    The directed movement of a motile cell or organism towards a higher concentration of a chemical.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0043406    positive regulation of MAP kinase activity    Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0043536    positive regulation of blood vessel endothelial cell migration    Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
    GO:0060045    positive regulation of cardiac muscle cell proliferation    Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
    GO:0051781    positive regulation of cell division    Any process that activates or increases the frequency, rate or extent of cell division.
    GO:0042660    positive regulation of cell fate specification    Any process that activates or enables a cell to adopt a specific fate.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:2000546    positive regulation of endothelial cell chemotaxis to fibroblast growth factor    Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
    GO:0001938    positive regulation of endothelial cell proliferation    Any process that activates or increases the rate or extent of endothelial cell proliferation.
    GO:0043552    positive regulation of phosphatidylinositol 3-kinase activity    Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
    GO:0010863    positive regulation of phospholipase C activity    Any process that increases the rate of phospholipase C activity.
    GO:1903672    positive regulation of sprouting angiogenesis    Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0045893    positive regulation of transcription, DNA-templated    Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0045765    regulation of angiogenesis    Any process that modulates the frequency, rate or extent of angiogenesis.
    GO:2000544    regulation of endothelial cell chemotaxis to fibroblast growth factor    Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
    GO:0014066    regulation of phosphatidylinositol 3-kinase signaling    Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0051209    release of sequestered calcium ion into cytosol    The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the cytosolic compartment.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0035019    somatic stem cell population maintenance    Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
    GO:0042060    wound healing    The series of events that restore integrity to a damaged tissue, following an injury.
cellular component
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Chain E,F,G,H   (FGFR2_HUMAN | P21802)
molecular function
    GO:0016303    1-phosphatidylinositol-3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0005088    Ras guanyl-nucleotide exchange factor activity    Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
    GO:0017134    fibroblast growth factor binding    Interacting selectively and non-covalently with a fibroblast growth factor.
    GO:0005007    fibroblast growth factor-activated receptor activity    Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0008201    heparin binding    Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0046934    phosphatidylinositol-4,5-bisphosphate 3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0009887    animal organ morphogenesis    Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
    GO:0006915    apoptotic process    A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
    GO:0007409    axonogenesis    De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon.
    GO:0060348    bone development    The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
    GO:0030282    bone mineralization    The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
    GO:0060349    bone morphogenesis    The process in which bones are generated and organized.
    GO:0060667    branch elongation involved in salivary gland morphogenesis    The differential growth of the salivary branches along their axis, resulting in the growth of a branch.
    GO:0060670    branching involved in labyrinthine layer morphogenesis    The process in which the branches of the fetal placental villi are generated and organized. The villous part of the placenta is called the labyrinth layer.
    GO:0060442    branching involved in prostate gland morphogenesis    The process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
    GO:0060445    branching involved in salivary gland morphogenesis    The process in which the branching structure of the salivary gland is generated and organized.
    GO:0048755    branching morphogenesis of a nerve    The process in which the anatomical structures of branches in a nerve are generated and organized. This term refers to an anatomical structure (nerve) not a cell (neuron).
    GO:0060449    bud elongation involved in lung branching    The process in which a bud in the lung grows out from the point where it is formed.
    GO:0045165    cell fate commitment    The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
    GO:0007267    cell-cell signaling    Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
    GO:0048565    digestive tract development    The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
    GO:0048701    embryonic cranial skeleton morphogenesis    The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
    GO:0048557    embryonic digestive tract morphogenesis    The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed.
    GO:0048568    embryonic organ development    Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
    GO:0048562    embryonic organ morphogenesis    Morphogenesis, during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
    GO:0009880    embryonic pattern specification    The process that results in the patterns of cell differentiation that will arise in an embryo.
    GO:0048730    epidermis morphogenesis    The process in which the anatomical structures of the epidermis are generated and organized. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
    GO:0030855    epithelial cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
    GO:0060664    epithelial cell proliferation involved in salivary gland morphogenesis    The multiplication or reproduction of epithelial cells of the submandibular salivary gland, resulting in the expansion of a cell population and the shaping of the gland.
    GO:0001837    epithelial to mesenchymal transition    A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0008543    fibroblast growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
    GO:0035603    fibroblast growth factor receptor signaling pathway involved in hemopoiesis    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which contributes to hemopoiesis.
    GO:0060595    fibroblast growth factor receptor signaling pathway involved in mammary gland specification    The series of molecular signals initiated by binding of a fibroblast growth factor to its receptor on the surface of al cell in the epidermis resulting in the formation of the mammary line. The mammary line is a ridge of epidermal cells that will form the mammary placodes.
    GO:0035602    fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.
    GO:0035607    fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development    The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.
    GO:0035604    fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.
    GO:0022612    gland morphogenesis    The process in which the anatomical structures of a gland are generated and organized.
    GO:0031069    hair follicle morphogenesis    The process in which the anatomical structures of the hair follicle are generated and organized.
    GO:0001701    in utero embryonic development    The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
    GO:0042472    inner ear morphogenesis    The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
    GO:0032808    lacrimal gland development    The process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye.
    GO:0060601    lateral sprouting from an epithelium    The process in which a branch forms along the side of an epithelium.
    GO:0060174    limb bud formation    The process pertaining to the initial formation of a limb bud from unspecified parts. This process begins with the formation of a local condensation of mesenchyme cells within the prospective limb field, and ends when a limb bud is recognizable.
    GO:0048286    lung alveolus development    The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
    GO:0030324    lung development    The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
    GO:0060463    lung lobe morphogenesis    The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung.
    GO:0060484    lung-associated mesenchyme development    The biological process whose specific outcome is the progression of a lung-associated mesenchyme from an initial condition to its mature state. This process begins with the formation of lung-associated mesenchyme and ends with the mature structure. Lung-associated mesenchyme is the tissue made up of loosely connected mesenchymal cells in the lung.
    GO:0060615    mammary gland bud formation    The morphogenetic process in which a bud forms from the mammary placode. A mammary bud is bulb of epithelial cells that is distinct from the surrounding epidermis.
    GO:0003149    membranous septum morphogenesis    The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
    GO:0048762    mesenchymal cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
    GO:0060915    mesenchymal cell differentiation involved in lung development    The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell of the lung. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
    GO:0060916    mesenchymal cell proliferation involved in lung development    The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population that contributes to the progression of the lung over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
    GO:0048333    mesodermal cell differentiation    The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.
    GO:0030901    midbrain development    The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
    GO:0016331    morphogenesis of embryonic epithelium    The process in which the anatomical structures of embryonic epithelia are generated and organized.
    GO:0035264    multicellular organism growth    The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
    GO:0050680    negative regulation of epithelial cell proliferation    Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
    GO:0000122    negative regulation of transcription from RNA polymerase II promoter    Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0042476    odontogenesis    The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
    GO:0021769    orbitofrontal cortex development    The progression of the orbitofrontal cortex over time from its initial formation until its mature state. The orbitofrontal cortex is a cerebral cortex region located in the frontal lobe.
    GO:0035265    organ growth    The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function.
    GO:0030916    otic vesicle formation    The process resulting in the transition of the otic placode into the otic vesicle, a transient embryonic structure formed during development of the vertebrate inner ear.
    GO:0003148    outflow tract septum morphogenesis    The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0046854    phosphatidylinositol phosphorylation    The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
    GO:0036092    phosphatidylinositol-3-phosphate biosynthetic process    The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
    GO:0048015    phosphatidylinositol-mediated signaling    A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0030177    positive regulation of Wnt signaling pathway    Any process that activates or increases the frequency, rate or extent of Wnt signal transduction.
    GO:0090263    positive regulation of canonical Wnt signaling pathway    Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
    GO:0060045    positive regulation of cardiac muscle cell proliferation    Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
    GO:0045787    positive regulation of cell cycle    Any process that activates or increases the rate or extent of progression through the cell cycle.
    GO:0051781    positive regulation of cell division    Any process that activates or increases the frequency, rate or extent of cell division.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0050679    positive regulation of epithelial cell proliferation    Any process that activates or increases the rate or extent of epithelial cell proliferation.
    GO:0060501    positive regulation of epithelial cell proliferation involved in lung morphogenesis    Any process that increases the rate or frequency of epithelial cell proliferation that results in the lung attaining its shape.
    GO:0002053    positive regulation of mesenchymal cell proliferation    The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
    GO:0010518    positive regulation of phospholipase activity    Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
    GO:0048661    positive regulation of smooth muscle cell proliferation    Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0009791    post-embryonic development    The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
    GO:0060527    prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis    The branching morphogenesis process in which the prostate epithelial cords branch freely to create the structure of the prostate acini.
    GO:0060523    prostate epithelial cord elongation    The developmental growth process in which solid chords of prostate epithelium increase in length.
    GO:0060512    prostate gland morphogenesis    The process in which the anatomical structures of a prostate gland are generated and organized.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0021860    pyramidal neuron development    The progression of a pyramidal neuron from its initial formation to its mature state.
    GO:0070372    regulation of ERK1 and ERK2 cascade    Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0060687    regulation of branching involved in prostate gland morphogenesis    Any process that modulates the rate, frequency, or extent of prostate gland branching, the process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
    GO:0010453    regulation of cell fate commitment    Any process that modulates the frequency, rate or extent of cell fate commitment. Cell fate commitment is the commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
    GO:0040036    regulation of fibroblast growth factor receptor signaling pathway    Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
    GO:0060688    regulation of morphogenesis of a branching structure    Any process that modulates the rate, frequency, or extent of branching morphogenesis, the process in which the anatomical structures of branches are generated and organized.
    GO:0040014    regulation of multicellular organism growth    Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
    GO:0045667    regulation of osteoblast differentiation    Any process that modulates the frequency, rate or extent of osteoblast differentiation.
    GO:0033688    regulation of osteoblast proliferation    Any process that modulates the frequency, rate or extent of osteoblast proliferation.
    GO:0014066    regulation of phosphatidylinositol 3-kinase signaling    Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0051150    regulation of smooth muscle cell differentiation    Any process that modulates the frequency, rate or extent of smooth muscle cell differentiation.
    GO:0008589    regulation of smoothened signaling pathway    Any process that modulates the frequency, rate or extent of smoothened signaling.
    GO:0048608    reproductive structure development    The reproductive developmental process whose specific outcome is the progression of structures that will be used in the process of creating new individuals from one or more parents, from their formation to the mature structures.
    GO:0048705    skeletal system morphogenesis    The process in which the anatomical structures of the skeleton are generated and organized.
    GO:0060529    squamous basal epithelial stem cell differentiation involved in prostate gland acinus development    The process in which a relatively unspecialized epithelial cell acquires specialized features of a squamous basal epithelial stem cell of the prostate.
    GO:0001657    ureteric bud development    The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
    GO:0055010    ventricular cardiac muscle tissue morphogenesis    The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
    GO:0021847    ventricular zone neuroblast division    The proliferation of neuroblasts in the ventricular zone of the cerebral cortex. The neuronal progenitors of these cells will migrate radially.
cellular component
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:0005938    cell cortex    The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031410    cytoplasmic vesicle    A vesicle found in the cytoplasm of a cell.
    GO:0060076    excitatory synapse    A synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell.
    GO:0031012    extracellular matrix    A structure lying external to one or more cells, which provides structural support for cells or tissues.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0043231    intracellular membrane-bounded organelle    Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005654    nucleoplasm    That part of the nuclear content other than the chromosomes or the nucleolus.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
(no "Ligands, Modified Residues, Ions" information available for 1iil)
 
  Sites
(no "Sites" information available for 1iil)
 
  Cis Peptide Bonds
    Asn E:184 - Pro E:185   [ RasMol ]  
    Asn F:184 - Pro F:185   [ RasMol ]  
    Asn G:184 - Pro G:185   [ RasMol ]  
    Asn H:184 - Pro H:185   [ RasMol ]  
    Leu E:262 - Pro E:263   [ RasMol ]  
    Leu F:262 - Pro F:263   [ RasMol ]  
    Leu G:262 - Pro G:263   [ RasMol ]  
    Leu H:262 - Pro H:263   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]
    Biological Unit 3  [ Jena3D ]
    Biological Unit 4  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1iil
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FGF2_HUMAN | P09038
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  FGFR2_HUMAN | P21802
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.1.112
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  101200
    Disease InformationOMIM
  101600
    Disease InformationOMIM
  123150
    Disease InformationOMIM
  123500
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FGF2_HUMAN | P09038
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  FGFR2_HUMAN | P21802
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FGF2_HUMAN | P090381bas 1bfb 1bfc 1bff 1bfg 1bla 1bld 1cvs 1ev2 1fga 1fq9 1ii4 2bfh 2fgf 2m49 4fgf 4oee 4oef 4oeg
        FGFR2_HUMAN | P218021djs 1e0o 1ev2 1gjo 1ii4 1nun 1oec 1wvz 2fdb 2psq 2pvf 2pvy 2pwl 2py3 2pz5 2pzp 2pzr 2q0b 3b2t 3caf 3cly 3cu1 3dar 3euu 3oj2 3ojm 3ri1 4j23 4j95 4j96 4j97 4j98 4j99 4wv1 5eg3 5ugl 5ugx 5uhn 5ui0

(-) Related Entries Specified in the PDB File

1ev2 CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
1ii4 CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2